Poland· PL-100016386

Cyclonamine

A etamsylate product containing etamsylatum, registered in Poland by Farmaceutyczna Spółdzielnia Pracy GALENA. The same ATC class is registered in 6 of our 19 countries.

ATC B02BX01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCyclonamineATCB02BX01REGISTER NO.PL-100016386PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Etamsylate is registered in 6 of 19 countries.

Countries holding a registration under ATC B02BX01 (etamsylate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Etamsylate · ATC B02BX01

6 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Franceprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Etamsylatum
Manufacturer
Farmaceutyczna Spółdzielnia Pracy GALENA
Country
Poland (PL)
ATC code
B02BX01
ATC class
Etamsylate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990046416
  • gtin
    05909991431242

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Etamsylate in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etamsylate products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Belgium · Dicynone
  • Bulgaria · Дицинон, Циклонамин
  • Czechia · Cyclonamine, Dicynone 250
  • France · Dicynone
  • Hungary · Dicynone
  • Lithuania · Dicynone
  • Luxembourg · Dicynone®
  • Latvia · Dicynone
  • Romania · Etamsilat Zentiva
  • Slovenia · Dicynone
  • Slovakia · Cyclonamine, Dicynone 500

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/08aca15f-261f-4d9c-96bc-9386d16dccf0
GET /v1/drugs/08aca15f-261f-4d9c-96bc-9386d16dccf0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "250 mg",
  "packaging": "05909990046416 ¦ Rp ¦ 44262\n30 tabl.\n05909991431242 ¦ Rp ¦ 136530\n60 tabl.",
  "substance": "Etamsylatum 250 mg",
  "common_name": "Etamsylatum",
  "pl_product_id": "100016386",
  "pozwolenie_nr": "00464",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about etamsylate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.